This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $3.83 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Maxillary sinus augmentation with a synthetic cell-binding peptide: histological and histomorphometrical results in humans
33 Beyond risk factor modification, however, no specific treatment is recommended for asymptomatic patients with atrial premature contractions who have no other apparent structural, functional, or electrical abnormality
This receptor-mediated mechanism suggests potential for targeted therapy with minimal effects on normal tissues that do not express high levels of MC3R and MC4R
*By clicking Get Notified!, you agree to receive SMS order and shipping updates from Pure Prescriptions at the mobile number provided
Importance of Research into Rare Disease Teaching old drugs new tricks drug repurposing for rare diseases Last Updated: May 19, 2022 Written by Aimee Molineux Aimee graduated from the University of Oxford in 2021 with an undergraduate degree in Languages, including an exchange year at Kobe University in Hyogo, Japan
